Aranthan Jones II, Chief Corporate Affairs Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 14,500 shares at $19.69 ($286K) on 2021-07-26, disclosed to the SEC on 2021-07-27.
Open-market sale of $286k VNDA by Chief Corporate Affairs Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.69 | 7,250 | $143K | 50.0% |
| 2 | $19.69 | 7,250 | $143K | 50.0% |
| Total | $19.69 avg | 14,500 | $286K | 100% |
| Filing → |
| VNDA | SELL | 2021-03-03 | $139K | — | Filing → |
| VNDA | SELL | 2021-02-26 | $920K | — | Filing → |
| VNDA | SELL | 2020-08-14 | $85K | — | Filing → |